The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.

Interleukin 2 (IL-2), a T cell-derived cytokine, targets a variety of cells to induce their growth, differentiation, and functional activation. IL-2 inserts signals into the cells through IL-2 receptors expressed on cell surfaces to induce such actions. In humans, the functional IL-2 receptor consists of the subunit complexes of the alpha, beta and gamma chains, or the beta and gamma chains. The third component, the gamma chain, of IL-2 receptor plays a pivotal role in formation of the full-fledged IL-2 receptor, together with the beta chain, the gamma chain participates in increasing the IL-2 binding affinity and intracellular signal transduction. Moreover, the cytokine receptors for at least IL-2, IL-4, IL-7, IL-9, and IL-15 utilize the same gamma chain as an essential subunit. Interestingly, mutations of the gamma chain gene cause human X-linked severe combined immunodeficiency (XSCID) characterized by a complete or profound T cell defect. Among the cytokines sharing the gamma chain, at least IL-7 is essentially involved in early T cell development in the mouse organ culture system. The molecular identification of the gamma chain brought a grasp of the structures and functions of the cytokine receptor and an in-depth understanding of the cause of human XSCID. To investigate the mechanism of XSCID and development of gene therapy for XSCID, knockout mice for the gamma chain gene were produced that showed similar but not exactly the same phenotypes as human XSCID.

[1]  H. Ochs,et al.  Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently. , 1995, Blood.

[2]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[3]  I. Pastan,et al.  A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4 (*) , 1995, The Journal of Biological Chemistry.

[4]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[5]  B. Groner,et al.  Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Miyajima,et al.  Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. , 1995, The EMBO journal.

[7]  W. Paul,et al.  Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis , 1995, Molecular and cellular biology.

[8]  L. A. Burns,et al.  Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway , 1995, Molecular and cellular biology.

[9]  H. Rui,et al.  Activation of JAK3, but Not JAK1, Is Critical to Interleukin-4 (IL4) Stimulated Proliferation and Requires a Membrane-proximal Region of IL4 Receptor (*) , 1995, The Journal of Biological Chemistry.

[10]  R. Puri,et al.  Receptor for Interleukin 13 , 1995, The Journal of Biological Chemistry.

[11]  T. Taniguchi Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[12]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[13]  S. McKnight,et al.  Identification and purification of human Stat proteins activated in response to interleukin-2. , 1995, Immunity.

[14]  W. Leonard,et al.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.

[15]  N. Tanaka,et al.  Functional Analysis of the Human Interleukin 2 Receptor γ Chain Gene Promoter (*) , 1995, The Journal of Biological Chemistry.

[16]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[17]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[18]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Arai,et al.  Involvement of the interleukin‐2 receptor γ subunit in interleukin‐4‐dependent activation of mouse hematopoietic cells and splenic B cells , 1995, European journal of immunology.

[20]  I. Kerr,et al.  Activation of JAK kinases and STAT proteins by interleukin‐2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. , 1994, The EMBO journal.

[21]  A. Svejgaard,et al.  Interleukin‐2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes , 1994, European journal of immunology.

[22]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[23]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[24]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[25]  K. Sugamura,et al.  Preferential utilization of the immature JH segment and absence of somatic mutation in the CDR3 junction of the Ig H chain gene in three X-linked severe combined immunodeficiency patients. , 1994, International immunology.

[26]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[27]  F. Rieux-Laucat,et al.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. McKnight,et al.  An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.

[29]  N. Tanaka,et al.  Interleukin 2‐induced activation of JAK3: Possible involvement in signal transduction for c‐myc induction and cell proliferation , 1994, FEBS letters.

[30]  K. Sugamura,et al.  Expression of the mouse interleukin‐2 receptor γ chain in various cell populations of the thymus and spleen , 1994, European journal of immunology.

[31]  S. Nishikawa,et al.  Implication of the common γ chain of the IL-7 receptor in intrathymic development of pro-T cells , 1994 .

[32]  K. Sugamura,et al.  Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex , 1994 .

[33]  T. Taniguchi,et al.  Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4, and IL-7 signalling , 1994, Molecular and cellular biology.

[34]  K. Sugamura,et al.  Expression of the IL-2 receptor γ chain on various populations in human peripheral blood , 1994 .

[35]  H. Asao,et al.  Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency. , 1994, Journal of immunology.

[36]  N. Tanaka,et al.  Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Kendall A. Smith,et al.  Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells , 1994, The Journal of experimental medicine.

[38]  R. Abraham,et al.  The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line , 1994, The Journal of experimental medicine.

[39]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[40]  M. Erdos,et al.  Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling , 1994, Nature.

[41]  B. Nelson,et al.  Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation , 1994, Nature.

[42]  M. Goldsmith,et al.  The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements. , 1994, The Journal of biological chemistry.

[43]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[44]  O. Silvennoinen,et al.  Signaling by the cytokine receptor superfamily: JAKs and STATs. , 1994, Trends in biochemical sciences.

[45]  S. Nishikawa,et al.  Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. , 1994, Science.

[46]  J. Fargnoli,et al.  Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. , 1994, The Journal of biological chemistry.

[47]  G. Mills,et al.  SH2-dependent association of phosphatidylinositol 3'-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain. , 1994, The Journal of biological chemistry.

[48]  A. Fischer,et al.  Interleukin‐2 (IL‐2) receptor γ chain mutations in X‐linked severe combined immunodeficiency disease result in the loss of high‐affinity IL‐2 receptor binding , 1994, European journal of immunology.

[49]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[50]  K. Ravichandran,et al.  The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. , 1994, The Journal of biological chemistry.

[51]  K. Rajewsky,et al.  Development and proliferation of lymphocytes in mice deficient for both interleukins‐2 and ‐4 , 1994, European journal of immunology.

[52]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[53]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[54]  R. de Waal Malefyt,et al.  An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13- induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors , 1993, The Journal of experimental medicine.

[55]  K. Sugamura,et al.  Kinetic study of interleukin‐2 binding on the reconstituted interleukin‐2 receptor complexes including the human γ chain , 1993, European journal of immunology.

[56]  G. Zurawski,et al.  Receptors for interleukin‐13 and interleukin‐4 are complex and share a novel component that functions in signal transduction. , 1993, The EMBO journal.

[57]  R. Perlmutter,et al.  Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  H. Asao,et al.  Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[60]  T. Kishimoto,et al.  Cytokine receptors and signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  M. Tsudo,et al.  Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling , 1992, The Journal of experimental medicine.

[62]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[63]  T. Taniguchi,et al.  IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc , 1992, Cell.

[64]  J. Renauld,et al.  Expression cloning of the murine and human interleukin 9 receptor cDNAs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[65]  H. Asao,et al.  An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. , 1992, Journal of immunology.

[66]  H. Shibuya,et al.  c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  K. Yasukawa,et al.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[69]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[70]  K. Sugamura,et al.  Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. , 1991, International immunology.

[71]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[72]  W. Paul,et al.  Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .

[73]  M. Nakafuku,et al.  Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[74]  K. Sugamura,et al.  Macrophage–T Cell Interaction Is Essential for the Induction of p75 Interleukin 2 (IL–2) Receptor and IL–2 Responsiveness in Human CD4+ T Cells , 1991, Japanese journal of cancer research : Gann.

[75]  M. Hatakeyama,et al.  Signal transduction by interleukin 2 receptor beta chain: importance of the structural integrity as revealed by site-directed mutagenesis and generation of chimeric receptors. , 1991, International immunology.

[76]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[77]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[78]  B. Mayer,et al.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation , 1990, Journal of virology.

[79]  Yusuke Nakamura,et al.  The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment , 1990, Nucleic Acids Res..

[80]  K. Weinberg,et al.  Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. , 1990, The New England journal of medicine.

[81]  H. Asao,et al.  An associated molecule, p64, with high-affinity interleukin 2 receptor. , 1990, International immunology.

[82]  J. Gnarra,et al.  Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[83]  N. Flomenberg,et al.  Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells , 1990, The Journal of experimental medicine.

[84]  S. Reed,et al.  Regulation of T cell proliferation by IL-7. , 1990, Journal of immunology.

[85]  S. Ziegler,et al.  Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily , 1990, Cell.

[86]  K. Grabstein,et al.  Regulation of human T cell proliferation by IL-7. , 1990, Journal of immunology.

[87]  K. Sugamura,et al.  Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. , 1989, Journal of immunology.

[88]  T. Taniguchi,et al.  A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization , 1989, Cell.

[89]  A. Zlotnik,et al.  IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. , 1989, International immunology.

[90]  Alan I. Alpert,et al.  The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms , 1989, Cell.

[91]  K. Sugamura,et al.  Activation of peripheral blood T cells via the p75 interleukin 2 receptor , 1989, The Journal of experimental medicine.

[92]  E. Shevach,et al.  Interleukin 7 is a T-cell growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[93]  T. Taniguchi,et al.  Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. , 1989, Science.

[94]  H. Asao,et al.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor , 1989, The Journal of experimental medicine.

[95]  M. Tsudo,et al.  Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[96]  C. March,et al.  Stimulation of B-cell progenitors by cloned murine interleukin-7 , 1988, Nature.

[97]  J. Puck,et al.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. March,et al.  B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors , 1988, The Journal of experimental medicine.

[99]  B. Cullen,et al.  A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors , 1987, Nature.

[100]  W. Greene,et al.  Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[101]  K. Kato,et al.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins , 1987, The Journal of experimental medicine.

[102]  T. Waldmann,et al.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[103]  B. Cullen,et al.  Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. , 1986, Science.

[104]  A. Huang,et al.  Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. , 1986, Journal of immunology.

[105]  T. Honjo,et al.  Molecular cloning and structure of the human interleukin 2 receptor gene. , 1985, Nucleic acids research.

[106]  M. Kanehisa,et al.  Structure of the human interleukin-2 receptor gene. , 1985, Science.

[107]  G. Crabtree,et al.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor , 1984, Nature.

[108]  T. Honjo,et al.  Molecular cloning of cDNA encoding human interleukin-2 receptor , 1984, Nature.

[109]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.

[110]  R. Good,et al.  T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells. , 1979, The Journal of clinical investigation.

[111]  J. Hansen,et al.  Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. , 1977, The New England journal of medicine.

[112]  T. Taniguchi,et al.  Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. , 1995, Immunity.

[113]  N. Tanaka,et al.  The Common γ-Chain for Multiple Cytokine Receptors , 1995 .

[114]  K. Smith The interleukin 2 receptor. , 1988, Advances in immunology.

[115]  C. March,et al.  Cloning, sequence and expression of human interleukin-2 receptor , 1984, Nature.